Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 1, 2014, Pages 103-108

  Schulman, Carl I ^b   Uribarri, Jaime ^a   Cai, Weijing ^a   Manning, Ron ^b   Landy, David C ^b   Gallardo, Margaret ^b   Castillo, Angela ^b   Namias, Nicholas ^b   Striker, Gary E ^a   Livingstone, Alan ^b   Vlassara, Helen ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

dietary AGEs; glycation; nutrition; oxidative stress

Indexed keywords

6 N CARBOXYMETHYLLYSINE; METHYLGLYOXAL;

ACUTE DISEASE; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; COHORT ANALYSIS; DEMOGRAPHY; DISEASE COURSE; FEMALE; HUMAN; INJURY; INJURY SCALE; INJURY SEVERITY; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; YOUNG ADULT;

ACUTE DISEASE; ADULT; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INTENSIVE CARE UNITS; KINETICS; LONGITUDINAL STUDIES; LYSINE; MALE; MIDDLE AGED; PYRUVALDEHYDE; SEVERITY OF ILLNESS INDEX; WOUNDS AND INJURIES;

EID: 84891458650     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0834     Document Type: Article

References (24)

1. Miniño AM, Heron MP, Murphy SL, Kochanek KD. Centers for Disease Control and Prevention National Center for Health Statistics National Vital Statistics System. Deaths: final data for 2004. Natl Vital Stat Rep 2007;55:1-119.
2. Roumen RM, Hendriks T, van der Ven-Jongekrijg J, Nieuwenhuijzen GA, Sauerwein RW, van der Meer JW, et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma: relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993;218:769-76.
3. Ayala A, Wang P, Ba ZF, Perrin MM, Ertel W, Chaudry IH. Differential alterations in plasma IL-6 and TNF levels following and hemorrhage. Am J Physiol 1991;260:R167-R171.
4. Ertel W, Keel M, Bonaccio M, Steckholzer U, Gallati H, Kenney JS, et al. Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome. J Trauma 1995;39:879-85.
5. Martin C, Boisson C, Haccoun M, Thomachot L, Mege JL. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997;25:1813-9.
6. Waydhas C, Nast-Kolb D, Jochum M, Trupka A, Lenk S, Fritz H, et al. Inflammatory mediators, infection, sepsis, and multiple organ failure after severe trauma. Arch Surg 1992;127:460-7.
7. Roumen RM, Redl H, Schlag G, Zilow G, Sandtner W, Koller W, et al. Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. Crit Care Med 1995;23:474-80.
8. Partrick DA, Moore EE, Moore FA, Biffl WL, Barnett CC Jr. Release of anti-inflammatory mediators after major torso trauma correlates with the development of postinjury multiple organ failure. Am J Surg 1999;178:564-9.
9. Bopp C, Hofer S, Weitz J, Bierhaus A, Nawroth PP, Martin E, et al. sRAGE is elevated in septic patients and associated with patients outcome. J Surg Res 2008;147:79-83.
10. Abraham E. Unraveling the role of high mobility group box protein 1 in severe trauma. Crit Care 2009;13:1004-1005.
11. Vlassara H, Striker G. AGE restriction in diabetes mellitus: A paradigm shift. Nat Rev Encrinolo 2011;7:1610-6.
12. Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 2010;110:911-6.
13. Vlassara H, Cai W, Crandall J, Goldberg T, Oberstein R, Dardaine V, et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci USA 2002;99:15596-601.
14. Vlassara H, Cai W, Goodman S, Pyzik R, Yong A, Zhu L, et al. Protection against loss of innate defenses in adulthood by low AGE intake: role of a new anti-inflammatory AGE-receptor-1. J Clin Endocrinol Metab 2009;94:4483-91.
15. Uribarri J, Cai W, Ramdas M, Goodman S, Pyzick R, Chen X, et al. Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care 2011;34:1610-6.
16. Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Suzuki T, Ueda Y, et al. Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock. Pharmacol Res 2009;60:515-8.
17. Andrades ME, Lorenzi R, Nagai R, Fonseca Moreira JC, Ritter C, Dal-Pizzol F. Plasma glycation levels are associated with the severity of sepsis. Eur J Clin Invest 2012;42:1055-60.
18. Cai W, Gao QD, Zhu L, Peppa M, He C, Vlassara H. Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction. Mol Med 2002;8:337-46.
19. Linden E, Cai W, He JC, Xue C, Li Z, Winston J, et al. Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clin J Am Soc Nephrol 2008;3:691-8.
20. Rabbani N, Thornalley PJ. Glyoxalase in diabetes, obesity and related disorders. Semin Cell Dev Biol 2011;22:309-17.
21. Williams MA, Enquobahrie DA, Zimmer J, Qiu CF, Hevner K, Abetew D, et al. Maternal plasma advanced glycation end products concentrations in response to oral 50-gram glucose load in mid-pregnancy: A pilot study. Clin Lab 2012;58:1045-50.
22. Vlasselaers D. Blood glucose control in the intensive care unit: discrepancy between belief and practice. Crit Care 2010;14:145-146.
23. Castellanos MR, Rothman J, Kleiner M. Tight glycemic control in critically ill patients. J Am Med Assoc 2010;303:16.
24. Cai W, Ramdas M, Zhu L, Chen X, Striker GE, Vlassara H. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proc Natl Acad Sci USA 2012;109:15888-93.